There are limited data regarding the impact of bioresorbable polymer drug eluting stent (BP-DES) compared to durable polymer drug eluting stent (DP-DES) in patients treated with percutaneous coronary intervention using ultrathin stents in left main or bifurcations.
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) / Iannaccone, M., Barbero, U., De Benedictis, M., Imori, Y., Quadri, G., Trabattoni, D., Ryan, N., Venuti, G., Montabone, A., Wojakowski, W., Rognoni, A., Helft, G., Parma, R., De Luca, L., Autelli, M., Boccuzzi, G., Mattesini, A., Templin, C., Cerrato, E., Wańha, W., et al.. - In: BMC CARDIOVASCULAR DISORDERS. - ISSN 1471-2261. - ELETTRONICO. - 20:(2020), pp. 225-233. [10.1186/s12872-020-01420-5]
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)
Mattesini, Alessio;Cortese, Bernardo;di Mario, Carlo;
2020
Abstract
There are limited data regarding the impact of bioresorbable polymer drug eluting stent (BP-DES) compared to durable polymer drug eluting stent (DP-DES) in patients treated with percutaneous coronary intervention using ultrathin stents in left main or bifurcations.| File | Dimensione | Formato | |
|---|---|---|---|
|
Inannaccome M-BMC Cardiovascular Disorders 2020.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
877.03 kB
Formato
Adobe PDF
|
877.03 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



